Amarjot Kaur

3.9k citations

73 papers · 2.8k indexed · 1 hit paper · h-index 30

Impact in

Immunology and Allergy top 0.5%
- Allergic Rhinitis and Sensitization
- Food Allergy and Anaphylaxis Research
Dermatology top 1%
- Dermatology and Skin Diseases

Papers in

Immunology and Allergy 25
- Allergic Rhinitis and Sensitization 25
- Food Allergy and Anaphylaxis Research 4
Physiology 28
- Asthma and respiratory diseases 22

Co-authors: Thakur Gurjeet Singh Heena Khan Hendrik Nolte Sean Curtis Loren Laine Christopher P. Cannon David I. Bernstein Jennifer Maloney
Journals: Journal of Allergy and Clinical Immunology (12 papers)Annals of Allergy Asthma & Immunology (6 papers)Neurochemical Research (5 papers)Inflammation Research (3 papers)The Lancet (3 papers)
Partner nations: United States India Canada

In The Last Decade

Amarjot Kaur

70 papers receiving 2.7k citations

Hit Papers

align trajectories log scale

Traumatic Brain Injury: Mechanistic Insight on Pathophysiology and Potential Therapeutic Targets 2021 · 204 citations

Peers

Countries citing papers authored by Amarjot Kaur

Since Specialization

Citations

This map shows the geographic impact of Amarjot Kaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amarjot Kaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amarjot Kaur more than expected).

Fields of papers citing papers by Amarjot Kaur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amarjot Kaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amarjot Kaur. The network helps show where Amarjot Kaur may publish in the future.

Co-authors

The 25 scholars most cited alongside Amarjot Kaur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amarjot Kaur Line = papers co-authored together Amarjot Kaur links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Exploring therapeutic potential: Targeting TRPM7 in neurodegenerative diseases International Immunopharmacology ·Rodolfo Rolón, Heena Khan, Samrat Chauhan, Amarjot Kaur, 游海华, P. Bashford, Dew-Anne Langcaon	2024	4
2	Therapeutic implications of phosphorylation- and dephosphorylation-dependent factors of cAMP-response element-binding protein (CREB) in neurodegeneration Pharmacological Reports ·Gilbert A. Cortes, Heena Khan, Amarjot Kaur, Thakur Gurjeet Singh	2023	20
3	Emerging Targets for Modulation of Immune Response and Inflammation in Stroke Neurochemical Research ·Komal Thapa, Shivam Kumar, Heena Khan, Amarjot Kaur, Kamal Dua, Sachin Kumar Singh, Thakur Gurjeet Singh	2023	14
4	Therapeutic implications of cyclooxygenase (COX) inhibitors in ischemic injury Inflammation Research ·Heena Khan, Kunal Sharma, Amit Kumar, Amarjot Kaur, Thakur Gurjeet Singh	2022	40
5	Therapeutic and mechanistic intervention of vitamin D in neuropsychiatric disorders Psychiatry Research ·Nicole Tartaglia, Heena Khan, Amarjot Kaur, Thakur Gurjeet Singh, Mohamed M. Abdel‐Daim	2022	24
6	Calpain Inhibitors as Potential Therapeutic Modulators in Neurodegenerative Diseases Neurochemical Research ·Heena Khan, Nikhil Garg, Thakur Gurjeet Singh, Amarjot Kaur, Komal Thapa	2022	37
7	Mechanistic Interventions of Selected Ocimum Species in Management of Diabetes, Obesity and Liver Disorders: Transformative Developments from Preclinical to Clinical Approaches Biointerface Research in Applied Chemistry ·Nikhil Garg, Thakur Uttam Singh, Heena Khan, Sandeep Arora, Amarjot Kaur, Ashi Mannan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2021	18
8	Mechanistic and physiological approaches of fecal microbiota transplantation in the management of NAFLD Inflammation Research ·Manisha Gupta, Pawan Krishan, Amarjot Kaur, Sandeep Arora, Nirupma Trehanpati, Thakur Gurjeet Singh, Onkar Bedi	2021	17
9	PRECLINICAL AND CLINICAL PERSPECTIVES OF Curculigo orchioides (Kali musali) AS THERAPEUTIC MODULATOR PLANT CELL BIOTECHNOLOGY AND MOLECULAR BIOLOGY ·G. R. da Cunha, Heena Khan, Thakur Gurjeet Singh, Saurabh Gupta, Amarjot Kaur	2021	3
10	Traumatic Brain Injury: Mechanistic Insight on Pathophysiology and Potential Therapeutic Targets Journal of Molecular Neuroscience ·Komal Thapa, Heena Khan, Thakur Gurjeet Singh, Amarjot Kaur Hit paper breakdown →	2021	204
11	Neuropeptides: Potential neuroprotective agents in ischemic injury Life Sciences ·Tanja Buwalda, Heena Khan, Saurabh Gupta, Amarjot Kaur, Thakur Gurjeet Singh	2021	38
12	Cyclic nucleotide phosphodiesterase inhibition as a potential therapeutic target in renal ischemia reperfusion injury Life Sciences ·Komal Thapa, Thakur Gurjeet Singh, Amarjot Kaur	2021	9
13	Pathobiological and molecular connections involved in the high fructose and high fat diet induced diabetes associated nonalcoholic fatty liver disease Inflammation Research ·英信中島, Simone Gomide dos Santos, Amarjot Kaur, Thakur Gurjeet Singh, Onkar Bedi	2020	16
14	Evaluation of SQ-House Dust Mite Sublingual Immunotherapy Tablet One-Year after Completion of a 24-Week Treatment Period Journal of Allergy and Clinical Immunology ·Petra Zieglmayer, Hendrik Nolte, Harold S. Nelson, David I. Bernstein, Amarjot Kaur, Ziliang Li, René Zieglmayer, René Schmutz, Patrick Lemell, Friedrich Horak	2016	1
15	Long-term effects of a house dust mite sublingual immunotherapy tablet in an environmental exposure chamber trial Annals of Allergy Asthma & Immunology ·Petra Zieglmayer, Hendrik Nolte, Harold S. Nelson, David I. Bernstein, Amarjot Kaur, Henrik H. Jacobi, Patrick Lemell, René Schmutz, René Zieglmayer, Friedrich Horak	2016	20
16	The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children Allergy Asthma and Clinical Immunology ·Jacques Hébert, Michael S. Blaiss, Susan Waserman, Harold Kim, Peter S. Creticos, Jennifer Maloney, Amarjot Kaur, Ziliang Li, Harold S. Nelson, Hendrik Nolte	2014	4
17	Safety and tolerability of a short ragweed sublingual immunotherapy tablet Annals of Allergy Asthma & Immunology ·Hendrik Nolte, Niran J. Amar, David I. Bernstein, Bobby Q. Lanier, Peter S. Creticos, Gary Berman, Amarjot Kaur, Jacques Hébert, Jennifer Maloney	2014	41
18	Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults Annals of Allergy Asthma & Immunology ·Hendrik Nolte, Jacques Hébert, Gary Berman, Sandra M. Gawchik, Martha V. White, Amarjot Kaur, Nancy Liu, William R. Lumry, Jennifer Maloney	2013	84
19	Airway obstruction lability helps distinguish levels of disease activity in asthma Respiratory Medicine ·Steven Greenberg, Nancy Liu, Amarjot Kaur, Mani Lakshminarayanan, Yijie Zhou, Linda Nelsen, Steven S. Smugar, Gertrude Noonan, Theodore F. Reiss, Barbara Knorr	2012	5
20	Baseline Factors Associated with Congestive Heart Failure in Patients Receiving Etoricoxib or Diclofenac: Multivariate Analysis of the MEDAL Program European Journal of Heart Failure ·Henry Krum, Sean Curtis, Amarjot Kaur, Hongwei Wang, Steven S. Smugar, Matthew R. Weir, Loren Laine, D. Craig Brater, Christopher P. Cannon	2009	13

About Amarjot Kaur

Amarjot Kaur is a scholar working on Immunology and Allergy, Physiology, Dermatology, Biochemistry and Pharmacology, having authored 73 papers that have together received 2.8k indexed citations. Recurring topics across this work include Allergic Rhinitis and Sensitization (25 papers), Asthma and respiratory diseases (22 papers), Respiratory and Cough-Related Research (10 papers), Inflammatory mediators and NSAID effects (9 papers), Dermatology and Skin Diseases (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Food Allergy and Anaphylaxis Research (4 papers). The work is most often cited by research in Immunology and Allergy (876 citations), Dermatology (444 citations), Pharmacology (673 citations), Physiology (1.0k citations) and Biochemistry (149 citations). Amarjot Kaur has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Thakur Gurjeet Singh, Heena Khan, Hendrik Nolte, Sean Curtis, Loren Laine, Christopher P. Cannon, David I. Bernstein, Jennifer Maloney, Komal Thapa and Harold S. Nelson. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Annals of Allergy Asthma & Immunology, Neurochemical Research, Inflammation Research and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact